EPIDEMIOLOGICAL, CLINICAL AND GENETIC CHARACTERISTICS OF ANORECTAL MALFORMATIONS (REVIEW)
Abstract
About the Authors
Yu. V. VydrychRussian Federation
N. S. Demikova
Russian Federation
Yu. N. Filyushkin
Russian Federation
S. G. Kalinenkova
Russian Federation
M. A. Podolnaya
Russian Federation
A. S. Lapina
Russian Federation
A. E. Mashkov
Russian Federation
A. Yu. Asanov
Russian Federation
References
1. Hartman EE, Oort FJ, Aronson DC, Sprangers MA. Quality of life and disease-specific functioning of patients with anorectal malformations or Hirschsprung’s disease: a review. 2011 Arch Dis Child, 2011; 96:398 - 406.
2. Stephens FD, Smith DE. Anorectal malformations in children. Chicago: Yearbook Publishers Inc. 1971; p 133.
3. Stephens FD, Smith ED, Paoul NW. Anorectal malformations in children: update. March of Dimes Birth Defect Foundation Original series, 1988; vol. 24
4. Stephens FD, Durham-Smith E. Classification, identification, and assessment of surgical treatment of anorectal anomalies. Pediatr Surg Int, 1986; 1: 200 - 205.
5. Pena A. Anorectal malformations. Semin Pediatr Surg. 1995;4:35 - 47
6. Ленюшкин А. И. Колопроктология детского возраста. Руководство для врачей. Медицина. 1999. - 365 С.
7. Smith ED. Incidence, frequency of types and aetiology of anorectal malformations. Birth Defects Orig Artic, 1988; Ser 24 (4):231 - 246
8. Harris J, Kallen B, Robert E. Descriptive epidemiology of alimentary tract atresia. Teratology, 1995; 52:15 - 29.
9. A Cuschieri and EUROCAT Working Group. Descriptive Epidemiology of Isolated Anal Anomalies: A Survey of 4.6 Million Birth in Europe. Am J Med Genet, 2001; 103: 207 - 15.
10. Forrester MB, Merz RD. Risk of Selected Birth Defects with Prenatal Illicit Drug Use, Hawaii, 1986 - 2002. J Toxicol Environ Health A. 2007; 70: 7 - 18.
11. Sun G, Xu ZM, Laing JF, LiL, Tang DX. Twelve-year prevalence of common neonatal congenital malformations in Zhejiang Province, China. World J Pediatr, 2011; 7: 331 - 336
12. Almaramhy, Hamdi H. Incidence and spectrum of anorectal malformations in Western Saudi Arabia. Saudi Medical Journal, 2012: Vol. 33, No 12:
13. Stoll C, Alembik Y, Roth MP, Dott B. Risk factors in congenital analatresias. Ann Genet. 1997; 40: 197 - 204.
14. Yang JH, et al. A multi-center study for birth defect monitoring. Arch Pediatr Adolesc Med, 2004; 155: 587 - 591
15. Landau, D., Mordechai, J., Karplus, M., Carmi, R. Inheritance of familial congenital isolated anorectal malformations: case report and review. Am. J. Med. Genet, 1997; 71: 280 - 282.
16. Falcone RA Jr, MA Levitt, A Peña, M Mates, Increased heritability of certain types of anorectal malformations. J Pediatr Surg, 2007; 42, 124 - 8.
17. Wijers CH, de Blaauw I, Marcelis CL, et al. Research perspectives in the etiology of congenital anorectal malformations using data of the International Consortium on Anorectal Malformations: evidence for risk factors across different populations. Pediatr Surg Int, 2010; 26:1093 - 1099
18. Zhang J, Zhang ZB, Gao H, et al. Down-regulation of SHH/BMP4 Signalling in Human Anorectal Malformations. J Int Med Res, 2009; 37:1842 - 1850
19. Carter TC, Kay DM, Browne ML, et al. Anorectal atresia and variants at predicted regulatory sites in candidate genes. AnnHumGenet, 2013; 77:31 - 46
20. Moore SW, Zaahl MG. Association of endothelin-beta receptor (EDNRB) gene variants in anorectal malformations. J Pediatr Surg. 2007 Jul; 42 (7):1266 - 70
21. Zhang T, Tang XB, Wang LL, et al. Mutations and down-regulation of CDX1 in children with anorectal malformations. Int J MedSci, 2013; 10:191 - 197
22. Lickert H., Domon C., Huls G., Wehrle C., Duluc I., Clevers H. et al. Wnt/ (beta) - catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine. Development, 2000; 127: 3805 - 3813
23. Wong EH, Cui L, Ng CL, et al. Genome-wide copy number variation study in anorectal malformations. Hum Mol Genet, 2013; 22: 621 - 631
24. Wijers CH, van Rooij IA, Marcelis CL et al. Genetic and nongenetic etiology of nonsyndromic anorectal malformations: a systematic review. Birth Defects Res C Embryo Today 2014;102:382 - 400.
25. Hay S, Barbano H. Independent effects of maternal age and birth order on the incidence of selected congenital malformations. Teratology 1972; 6:271 - 279.
26. Myers MF, Li S, Correa-Villaseñor A, et al. Folic acid supplementation and risk for imperforate anus in China. Am J Epidemiol 2001;154:1051 - 1056.
27. van Rooij IA, Wijers CH, Rieu PN, et al. Maternal and Paternal Risk Factors for anorectalMalformations: A Dutch Case-Control Study. Birth Defects Res A ClinMolTeratol, 2010; 88, 152 - 8
28. Wijers CHW, van Rooij IALM, Bakker MK, et al. Anorectal malformations and pregnancy-related disorders: a registry-based case-control study in 17 European regions. BJOG 2013; 120:1066 - 1074.
29. Forrester MB, Merz RD. Descriptive epidemiology of anal atresia in Hawaii, 1986 - 1999. Teratology 2002; 66 Suppl 1: S12-16.
30. Miller EA, Manning SE, Rasmussen SA, et al. Maternal exposure to tobacco smoke, alcohol and caffeine, and risk of anorectal atresia: National Birth Defects Prevention Study 1997 - 2003. Paediatr Perinat Epidemiol, 2009; 23:9 - 17.
31. Källén B, Finnström O, Nygren KG, et al. In vitro fertilization (IVF) in Sweden: risk for congenital malformations after different IVF methods. Birth Defects Res A Clin Mol Teratol, 2005; 73:162 - 169.
32. Midrio P, Nogare CD, Di GE, et al. Are congenital anorectal malformations more frequent in newborns conceived with assisted reproductive techniques? Reprod Toxicol 2006; 22:576 - 577.
33. Reefhuis J, Honein MA, Schieve LA, et al. Assisted reproductive technology and major structural birth defects in the United States. Hum Reprod., 2009; 24:360 - 366.
34. Zwink N, Jenetzky E, Schmiedeke E, et al. Assisted reproductive techniques and the risk of anorectal malformations: a German case-control study. Orphanet J Rare Dis, 2012; 7:65.
35. Waller DK, Shaw GM, Rasmussen SA, et al. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med, 2007; 161:745 - 750.
36. Frías JL, Frías JP, Frías PA, et al. Infrequently studied congenital anomalies as clues to the diagnosis of maternal diabetes mellitus. Am J Med Genet. A, 2007; 143A: 2904 - 2909.
37. Correa A, Gilboa SM, Besser LM, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol., 2008; 199:237 - 239.
38. Feldkamp ML, Meyer RE, Krikov S, et al. Acetaminophen use in pregnancy and risk of birth defects: findings from the National Birth Defects Prevention Study. Obstet Gynecol 2010; 115:109 - 115.
39. Broussard CS, Rasmussen SA, Reefhuis J, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011; 204:314 e311-311.
40. van Gelder MM, Roeleveld N, Nordeng H. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: a prospective cohort study. PLoS One 2011; 6: e221-274.
41. Crider KS, Cleves MA, Reefhuis J, et al. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med, 2009;163:978 - 985.
42. Reis M, Källén B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010; 40:1723 - 1733.
43. Bonnot O, Vollset SE, Godet PF, et al. Maternal exposure to lorazepam and anal atresia in newborns: results from a hypothesis-generating study of benzodiazepines and malformations. JClin Psychopharmacol, 2001; 21:456 - 458.
44. Eros E, Czeizel AE, Rockenbauer M, et al. A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2002; 101:147 - 154.
45. Czeizel AE, Eros E, Rockenbauer M, et al. Short-Term Oral Diazepam Treatment during Pregnancy: A Population-Based Teratological Case-Control Study. Clin Drug Investig 2003; 23:451 - 462.
46. Czeizel AE, Rockenbauer M, Sorensen HT, et al. A population-based case-control study of oral chlordiazepoxide use during pregnancy and risk of congenital abnormalities. Neurotoxicol Teratol, 2004;26:593 - 598.50
47. Kjaer D, Horvath-Puhó E, Christensen J, et al. Use of phenytoin, phenobarbital, or diazepam during pregnancy and risk of congenital abnormalities: a case-time-control study. Pharmacoepidemiol Drug Saf 2007; 16:181 - 188.
48. Herdt-Losavio ML, Lin S, Chapman BR, Hooiveld M, et al. Maternal occupation and the risk of birth defects: an overview from the National Birth Defects Prevention Study. Occup Environ Med., 2010; 67, 58 - 66. doi: 10.1136/oem. 2009.048256
49. Yuan P, Okazaki I, Kuroki Y. Anal atresia: effect of smoking and drinking habits during pregnancy. Jpn J Hum Genet. 40, 1995; 327 - 32
50. Zwink et al. Orphanet Journal of Rare Diseases, 2011; 6:25http://www.ojrd.com/content/6/1/25Page 15 of 16
51. Honein MA, Paulozzi LJ, Watkins ML, Maternal smoking and birth defects: validity of birth certificate data for effect estimation. Public Health Rep., 2001; 116,327 - 35.
52. Jenetzky E, Prevalence estimation of anorectal malformations using German diagnosis related groups system. PediatrSurgInt, 2007; 23:1161 - 1165
53. Holschneider A, Hutson J, Pen˜a A, Beket E, et al. Preliminary report on theInternational Conference for the Development of Standards forthe Treatment of Anorectal Malformations. J PediatrSurg, 2005; 40:1521 - 1526
54. Marcelis C, de Blaauw I, Brunner H. Chromosomal anomalies in the etiology of anorectal malformations: A review. Am J Med Genet Part A, 2011; 9999: 1 - 13 www.omim.org
55. Sam W Moore. Associations of anorectal malformations and related syndromes. Pediatr Surg Int, 2013; 29, 665 - 676
Review
For citations:
Vydrych Yu.V., Demikova N.S., Filyushkin Yu.N., Kalinenkova S.G., Podolnaya M.A., Lapina A.S., Mashkov A.E., Asanov A.Yu. EPIDEMIOLOGICAL, CLINICAL AND GENETIC CHARACTERISTICS OF ANORECTAL MALFORMATIONS (REVIEW). Experimental and Clinical Gastroenterology. 2016;(5):58-64. (In Russ.)